Nasdaq · CIK 0001743881
BBIO BridgeBio Pharma, Inc.
Insider trading from SEC Form 4. Last filing 21 d ago. Close $65.35 on Oct 9, 2026, +23% from the 52-week low and -28% from the high.
Last 90 days
Net insider value
-$691k
more sold than bought
Buys
0
$0 by 0 insiders
Sells
1
$691k by 1 insider
Insiders on file
13
with a Form 4 at this company
Price and insider trades, last year
BBIOOct 9, 2026 · close 65.35
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at BridgeBio Pharma, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 26Weak | Neil Kumar Chief Executive Officer sell | $691k 10,000 shares | -2% | - | |
| 50Moderate | Neil Kumar Chief Executive Officer sell | $5.5M 80,000 shares | -12% | +126% from low-15% from high | |
| 35Weak | Hannah Valantine director sell | $624k 8,671 shares | -54% | +147% from low-7% from high | |
| 40Moderate | Andrea Ellis director sell | $4.2M 64,921 shares | -78% | +121% from low-17% from high | |
| 40Moderate | Hannah Valantine director sell | $1.7M 25,484 shares | -77% | +121% from low-17% from high | |
| 21Weak | Maricel Apuli Chief Accounting Officer sell | $132k 2,000 shares | -2% | +124% from low-15% from high | |
| 50Moderate | Neil Kumar Chief Executive Officer sell | $2.0M 28,053 shares | -11% | +135% from low-12% from high | |
| 16Weak | Maricel Apuli Chief Accounting Officer sell | $38k 510 shares | -0% | +152% from low-5% from high | |
| 27Weak | Randal W. Scott director sell | $755k 10,000 shares | -46% | +152% from low-5% from high | |
| 42Moderate | Thomas Trimarchi President and CFO sell | $1.0M 13,600 shares | -4% | +152% from low-5% from high | |
| 50Moderate | Neil Kumar Chief Executive Officer sell | $5.7M 80,000 shares | -11% | +140% from low-9% from high | |
| 35Weak | Neil Kumar Chief Executive Officer sell | $6.0M 80,000 shares | -11% | +154% from low-6% from high | |
| 28Weak | Neil Kumar Chief Executive Officer sell | $2.2M 30,011 shares | -12% | +187% from low-1% from high | |
| 14Weak | Maricel Apuli Chief Accounting Officer sell | $149k 2,000 shares | -2% | +186% from low-1% from high | |
| 43Moderate | Neil Kumar Chief Executive Officer sell | $5.9M 80,000 shares | -10% | +188% from low0% from high | |
| 50Moderate | Neil Kumar Chief Executive Officer sell | $1.7M 26,156 shares | -10% | +180% from low-3% from high | |
| 25Weak | Randal W. Scott director sell | $666k 10,000 shares | -46% | +199% from low0% from high | |
| 75Notable | Andrew Lo director sell | $6.3M 95,599 shares | -175% | +199% from low0% from high | |
| 42Moderate | Thomas Trimarchi President and CFO sell | $1.1M 16,934 shares | -4% | +199% from low0% from high | |
| 60Notable | Hannah Valantine director sell | $1.7M 25,484 shares | -77% | +196% from low-1% from high | |
| 45Moderate | Neil Kumar Chief Executive Officer sell | $5.0M 80,000 shares | -2% | +181% from low-6% from high | |
| 60Notable | Ronald J Daniels director sell | $3.9M 61,031 shares | -78% | +181% from low-6% from high | |
| 40Moderate | Frank McCormick director sell | $13M 198,359 shares | -23% | +198% from low0% from high | |
| 20Weak | Frank McCormick director sell | $107k 1,641 shares | -0% | +184% from low0% from high | |
| 30Weak | Neil Kumar Chief Executive Officer sell | $4.4M 80,000 shares | -2% | +147% from low0% from high | |
| 43Moderate | Frank McCormick director sell | $3.9M 74,000 shares | -47% | +139% from low0% from high | |
| 45Moderate | Neil Kumar Chief Executive Officer sell | $4.2M 80,000 shares | -2% | +132% from low-1% from high | |
| 50Moderate | Neil Kumar Chief Executive Officer sell | $1.3M 26,156 shares | -10% | +119% from low-5% from high | |
| 62Notable | Thomas Trimarchi President and CFO sell | $2.1M 42,237 shares | -9% | +125% from low-2% from high | |
| 40Moderate | Thomas Trimarchi President and CFO sell | $872k 17,353 shares | -4% | +119% from low-4% from high | |
| 40Moderate | Charles J Homcy director sell | $14M 300,000 shares | -25% | +108% from low-5% from high | |
| 36Weak | Maricel Apuli Chief Accounting Officer sell | $45k 1,000 shares | -1% | +106% from low-7% from high | |
| 45Moderate | Neil Kumar Chief Executive Officer sell | $3.7M 80,000 shares | -2% | +106% from low-7% from high | |
| 28Weak | Andrea Ellis director sell | $841k 17,167 shares | -48% | +120% from low0% from high | |
| 45Moderate | Neil Kumar Chief Executive Officer sell | $3.4M 80,000 shares | -2% | +91% from low-5% from high | |
| 57Moderate | Viking Global Investors LP owner sell | $154M 3,500,000 shares | -16% | +101% from low-1% from high | |
| 52Moderate | Hannah Valantine director sell | $207k 4,707 shares | -48% | +102% from low0% from high | |
| 28Weak | Hannah Valantine director buy | $30k 2,338 shares | - | - | |
| 30Weak | Hannah Valantine director buy | $25k 1,752 shares | +114% | - | |
| 40Moderate | Frank McCormick director sell | $4.4M 100,000 shares | -10% | +99% from low0% from high | |
| 19Weak | Hannah Valantine director sell | $172k 4,292 shares | -71% | +79% from low0% from high | |
| 33Weak | Neil Kumar Chief Executive Officer sell | $3.4M 101,156 shares | -42% | +51% from low-13% from high | |
| 62Notable | KKR Genetic Disorder L.P. owner sell | $205M 6,000,000 shares | -31% | +60% from low-7% from high | |
| 36Weak | Maricel Apuli Chief Accounting Officer sell | $40k 1,026 shares | -1% | +73% from low0% from high | |
| 65Notable | Andrew Lo director sell | $3.8M 100,000 shares | -49% | +73% from low0% from high | |
| 45Moderate | Neil Kumar Chief Executive Officer sell | $2.6M 75,000 shares | -2% | +53% from low-9% from high | |
| 13Weak | Andrea Ellis director sell | $350k 10,000 shares | -45% | +56% from low-7% from high | |
| 33Weak | Andrea Ellis director sell | $1.0M 30,000 shares | -71% | +48% from low-12% from high | |
| 38Weak | Neil Kumar Chief Executive Officer sell | $2.8M 75,000 shares | -1% | +64% from low-2% from high | |
| 31Weak | Hannah Valantine director sell | $419k 12,875 shares | -88% | - | |
| 57Moderate | KKR Genetic Disorder L.P. owner sell | $198M 6,000,000 shares | -24% | - | |
| 45Moderate | Neil Kumar Chief Executive Officer sell | $2.5M 75,000 shares | -1% | - | |
| 16Weak | Brian C Stephenson CFO and Treasurer sell | $282k 8,500 shares | -8% | - | |
| 35Weak | Neil Kumar Chief Executive Officer sell | $1.1M 31,543 shares | -13% | - | |
| 13Weak | Brian C Stephenson Secretary, Treasurer & CFO sell | $150k 4,148 shares | -4% | - | |
| 57Moderate | Viking Global Investors LP owner sell | $107M 3,065,616 shares | -12% | - | |
| 50Moderate | Neil Kumar Chief Executive Officer sell | $22M 600,000 shares | -11% | - | |
| 37Weak | Brian C Stephenson Secretary, Treasurer & CFO sell | $2.5M 68,000 shares | -42% | - | |
| 20Weak | Brian C Stephenson Secretary, Treasurer & CFO sell | $93k 4,156 shares | -4% | - | |
| 33Weak | Neil Kumar Chief Executive Officer sell | $614k 27,389 shares | -1% | - |
Planned sales
Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales
| Filed | Seller | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Nov 19, 2024 | NEIL KUMAR Director, Officer | 27,389 0.01% of outstanding | $612k | Nov 19, 2024 | none |
| Nov 19, 2024 | BRIAN STEPHENSON Officer | 4,156 0.00% of outstanding | $93k | Nov 19, 2024 | none |
Congressional trades
7 trades in BBIO disclosed by members of Congress under the STOCK Act. All congressional trades.
- Gilbert Ray Cisneros, Jr.House · D-CA · last Jun 8, 20267 bought
0 sold
| Member | Trade | Asset | Reported range | Trade / filing date | Source |
|---|---|---|---|---|---|
Gilbert Ray Cisneros, Jr. House · D-CA | Purchase | BBIO BridgeBio Pharma, Inc. - Common Stock | $1,001 to $15k | May 11 / Jun 8 28 days after the trade | Clerk |
Gilbert Ray Cisneros, Jr. House · D-CA | Purchase | BBIO BridgeBio Pharma, Inc. - Common Stock | $1,001 to $15k | Apr 29 / May 8 9 days after the trade | Clerk |
Gilbert Ray Cisneros, Jr. House · D-CA | Purchase | BBIO BridgeBio Pharma, Inc. - Common Stock | $1,001 to $15k | Mar 3 / Apr 7 35 days after the trade | Clerk |
Gilbert Ray Cisneros, Jr. House · D-CA | Purchase | BBIO BridgeBio Pharma, Inc. - Common Stock | $1,001 to $15k | Mar 19 / Apr 7 19 days after the trade | Clerk |
Gilbert Ray Cisneros, Jr. House · D-CA | Purchase | BBIO BridgeBio Pharma, Inc. - Common Stock | $1,001 to $15k | Mar 18 / Apr 7 20 days after the trade | Clerk |
Gilbert Ray Cisneros, Jr. House · D-CA | Purchase | BBIO BridgeBio Pharma, Inc. - Common Stock | $1,001 to $15k | Sep 22, 2025 / Oct 10, 2025 18 days after the trade | Clerk |
Gilbert Ray Cisneros, Jr. House · D-CA | Purchase | BBIO BridgeBio Pharma, Inc. - Common Stock | $1,001 to $15k | Aug 8, 2025 / Sep 12, 2025 35 days after the trade | Clerk |
Transactions
The last 100 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 17, 2026 | Neil Kumar Chief Executive Officer | SOpen-market sale Common Stockindirect: By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -8,721 | $69.01 | $602k | 496,965 | 21 d ago |
| Sep 17, 2026 | Neil Kumar Chief Executive Officer | SOpen-market sale Common Stockindirect: By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -1,279 | $69.57 | $89k | 495,686 | 21 d ago |
| Mar 18, 2026 | Thomas Trimarchi President and CFO | AGrant or award Common Stock | +59,041 | $0.00 | $0 | 395,626 | Mar 20, 2026 |
| Mar 18, 2026 | Maricel Apuli Chief Accounting Officer | AGrant or award Common Stock | +14,170 | $0.00 | $0 | 136,115 | Mar 20, 2026 |
| Mar 17, 2026 | Neil Kumar Chief Executive Officer | AGrant or award Stock Option (Right to Buy)derivative | +40,570 | $0.00 | $0 | 40,570 | Mar 19, 2026 |
| Mar 17, 2026 | Neil Kumar Chief Executive Officer | AGrant or award Restricted Stock Unitsderivative | +104,313 | $0.00 | $0 | 104,313 | Mar 19, 2026 |
| Mar 12, 2026 | Neil Kumar Chief Executive Officer | SOpen-market sale Common Stockindirect: By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -14,337 | $68.48 | $982k | 661,349 | Mar 16, 2026 |
| Mar 12, 2026 | Neil Kumar Chief Executive Officer | SOpen-market sale Common Stockindirect: By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -5,363 | $69.32 | $372k | 655,986 | Mar 16, 2026 |
| Mar 12, 2026 | Neil Kumar Chief Executive Officer | SOpen-market sale Common Stockindirect: By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -300 | $70.15 | $21k | 655,686 | Mar 16, 2026 |
| Mar 12, 2026 | Neil Kumar Chief Executive Officer | SOpen-market sale Common Stockindirect: By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -13,885 | $68.47 | $951k | 4,464,562 | Mar 16, 2026 |
| Mar 12, 2026 | Neil Kumar Chief Executive Officer | SOpen-market sale Common Stockindirect: By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -5,815 | $69.29 | $403k | 4,458,747 | Mar 16, 2026 |
| Mar 12, 2026 | Neil Kumar Chief Executive Officer | SOpen-market sale Common Stockindirect: By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -300 | $70.15 | $21k | 4,458,447 | Mar 16, 2026 |
| Mar 13, 2026 | Neil Kumar Chief Executive Officer | SOpen-market sale Common Stockindirect: By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -9,690 | $68.36 | $662k | 645,996 | Mar 16, 2026 |
| Mar 13, 2026 | Neil Kumar Chief Executive Officer | SOpen-market sale Common Stockindirect: By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -10,310 | $69.20 | $713k | 635,686 | Mar 16, 2026 |
| Mar 13, 2026 | Neil Kumar Chief Executive Officer | SOpen-market sale Common Stockindirect: By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -10,241 | $68.39 | $700k | 4,448,206 | Mar 16, 2026 |
| Mar 13, 2026 | Neil Kumar Chief Executive Officer | SOpen-market sale Common Stockindirect: By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -9,759 | $69.23 | $676k | 4,438,447 | Mar 16, 2026 |
| Mar 10, 2026 | Hannah Valantine director | MOption exercise Common Stock10b5-1 | +8,671 | $27.36 | $237k | 16,136 | Mar 12, 2026 |
| Mar 10, 2026 | Hannah Valantine director | SOpen-market sale Common Stock10b5-1 | -8,671 | $72.00 | $624k | 7,465 | Mar 12, 2026 |
| Mar 10, 2026 | Hannah Valantine director | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -8,671 | $0.00 | $0 | 17,343 | Mar 12, 2026 |
| Mar 4, 2026 | Andrea Ellis director | MOption exercise Common Stock10b5-1 | +64,921 | $8.45 | $549k | 83,510 | Mar 6, 2026 |
| Mar 4, 2026 | Andrea Ellis director | SOpen-market sale Common Stock10b5-1 | -64,921 | $64.87 | $4.2M | 18,589 | Mar 6, 2026 |
| Mar 4, 2026 | Andrea Ellis director | MOption exercise Stock Option (right to buy)derivative10b5-1 | -64,921 | $0.00 | $0 | 0 | Mar 6, 2026 |
| Feb 27, 2026 | Hannah Valantine director | MOption exercise Common Stock10b5-1 | +25,484 | $48.45 | $1.2M | 32,949 | Mar 3, 2026 |
| Feb 27, 2026 | Hannah Valantine director | SOpen-market sale Common Stock10b5-1 | -14,584 | $67.08 | $978k | 18,365 | Mar 3, 2026 |
| Feb 27, 2026 | Hannah Valantine director | SOpen-market sale Common Stock10b5-1 | -10,900 | $67.84 | $739k | 7,465 | Mar 3, 2026 |
| Feb 27, 2026 | Hannah Valantine director | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -25,484 | $0.00 | $0 | 0 | Mar 3, 2026 |
| Feb 26, 2026 | Maricel Apuli Chief Accounting Officer | SOpen-market sale Common Stock10b5-1 | -2,000 | $66.00 | $132k | 121,945 | Feb 27, 2026 |
| Feb 19, 2026 | Neil Kumar Chief Executive Officer | SOpen-market sale Common Stock10b5-1 | -18,923 | $71.03 | $1.3M | 243,581 | Feb 23, 2026 |
| Feb 19, 2026 | Neil Kumar Chief Executive Officer | SOpen-market sale Common Stock10b5-1 | -8,528 | $72.08 | $615k | 235,053 | Feb 23, 2026 |
| Feb 19, 2026 | Neil Kumar Chief Executive Officer | SOpen-market sale Common Stock10b5-1 | -602 | $72.80 | $44k | 234,451 | Feb 23, 2026 |
| Feb 17, 2026 | Randal W. Scott director | MOption exercise Common Stock10b5-1 | +10,000 | $16.75 | $168k | 21,589 | Feb 18, 2026 |
| Feb 16, 2026 | Maricel Apuli Chief Accounting Officer | FTax withholding Common Stock10b5-1 | -4,349 | $75.25 | $327k | 124,455 | Feb 18, 2026 |
| Feb 16, 2026 | Thomas Trimarchi President and CFO | FTax withholding Common Stock10b5-1 | -18,819 | $75.25 | $1.4M | 350,185 | Feb 18, 2026 |
| Feb 16, 2026 | Neil Kumar Chief Executive Officer | MOption exercise Common Stock | +33,544 | - | - | 262,320 | Feb 18, 2026 |
| Feb 17, 2026 | Randal W. Scott director | SOpen-market sale Common Stock10b5-1 | -1,900 | $74.34 | $141k | 19,689 | Feb 18, 2026 |
| Feb 17, 2026 | Thomas Trimarchi President and CFO | SOpen-market sale Common Stock10b5-1 | -13,400 | $74.71 | $1.0M | 336,785 | Feb 18, 2026 |
| Feb 16, 2026 | Neil Kumar Chief Executive Officer | MOption exercise Common Stock | +19,600 | - | - | 281,920 | Feb 18, 2026 |
| Feb 17, 2026 | Maricel Apuli Chief Accounting Officer | SOpen-market sale Common Stock10b5-1 | -510 | $74.31 | $38k | 123,945 | Feb 18, 2026 |
| Feb 17, 2026 | Thomas Trimarchi President and CFO | SOpen-market sale Common Stock10b5-1 | -200 | $75.38 | $15k | 336,585 | Feb 18, 2026 |
| Feb 16, 2026 | Neil Kumar Chief Executive Officer | MOption exercise Common Stock | +11,554 | - | - | 293,474 | Feb 18, 2026 |
| Feb 17, 2026 | Randal W. Scott director | SOpen-market sale Common Stock10b5-1 | -4,793 | $75.57 | $362k | 14,896 | Feb 18, 2026 |
| Feb 17, 2026 | Randal W. Scott director | SOpen-market sale Common Stock10b5-1 | -3,307 | $75.93 | $251k | 11,589 | Feb 18, 2026 |
| Feb 16, 2026 | Neil Kumar Chief Executive Officer | FTax withholding Common Stock | -30,970 | $75.25 | $2.3M | 262,504 | Feb 18, 2026 |
| Feb 17, 2026 | Randal W. Scott director | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -10,000 | $0.00 | $0 | 31,501 | Feb 18, 2026 |
| Feb 16, 2026 | Neil Kumar Chief Executive Officer | MOption exercise Restricted Stock Unitsderivative | -33,544 | $0.00 | $0 | 134,176 | Feb 18, 2026 |
| Feb 16, 2026 | Neil Kumar Chief Executive Officer | MOption exercise Restricted Stock Unitsderivative | -19,600 | $0.00 | $0 | 156,794 | Feb 18, 2026 |
| Feb 16, 2026 | Neil Kumar Chief Executive Officer | MOption exercise Restricted Stock Unitsderivative | -11,554 | $0.00 | $0 | 138,645 | Feb 18, 2026 |
| Feb 10, 2026 | Neil Kumar Chief Executive Officer | SOpen-market sale Common Stockindirect: By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -14,201 | $71.80 | $1.0M | 701,485 | Feb 12, 2026 |
| Feb 10, 2026 | Neil Kumar Chief Executive Officer | SOpen-market sale Common Stockindirect: By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -5,799 | $72.28 | $419k | 695,686 | Feb 12, 2026 |
| Feb 10, 2026 | Neil Kumar Chief Executive Officer | SOpen-market sale Common Stockindirect: By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -14,040 | $71.80 | $1.0M | 4,504,407 | Feb 12, 2026 |
| Feb 10, 2026 | Neil Kumar Chief Executive Officer | SOpen-market sale Common Stockindirect: By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -5,960 | $72.27 | $431k | 4,498,447 | Feb 12, 2026 |
| Feb 11, 2026 | Neil Kumar Chief Executive Officer | SOpen-market sale Common Stockindirect: By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -7,806 | $70.69 | $552k | 687,880 | Feb 12, 2026 |
| Feb 11, 2026 | Neil Kumar Chief Executive Officer | SOpen-market sale Common Stockindirect: By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -3,716 | $71.44 | $265k | 684,164 | Feb 12, 2026 |
| Feb 11, 2026 | Neil Kumar Chief Executive Officer | SOpen-market sale Common Stockindirect: By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -4,484 | $72.64 | $326k | 679,680 | Feb 12, 2026 |
| Feb 11, 2026 | Neil Kumar Chief Executive Officer | SOpen-market sale Common Stockindirect: By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -3,994 | $73.25 | $293k | 675,686 | Feb 12, 2026 |
| Feb 11, 2026 | Neil Kumar Chief Executive Officer | SOpen-market sale Common Stockindirect: By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -7,860 | $70.70 | $556k | 4,490,587 | Feb 12, 2026 |
| Feb 11, 2026 | Neil Kumar Chief Executive Officer | SOpen-market sale Common Stockindirect: By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -3,775 | $71.46 | $270k | 4,486,812 | Feb 12, 2026 |
| Feb 11, 2026 | Neil Kumar Chief Executive Officer | SOpen-market sale Common Stockindirect: By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -4,404 | $72.65 | $320k | 4,482,408 | Feb 12, 2026 |
| Feb 11, 2026 | Neil Kumar Chief Executive Officer | SOpen-market sale Common Stockindirect: By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -3,961 | $73.25 | $290k | 4,478,447 | Feb 12, 2026 |
| Jan 8, 2026 | Neil Kumar Chief Executive Officer | SOpen-market sale Common Stockindirect: By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -11,515 | $73.64 | $848k | 744,171 | Jan 12, 2026 |
| Jan 8, 2026 | Neil Kumar Chief Executive Officer | SOpen-market sale Common Stockindirect: By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -8,085 | $74.38 | $601k | 736,086 | Jan 12, 2026 |
| Jan 8, 2026 | Neil Kumar Chief Executive Officer | SOpen-market sale Common Stockindirect: By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -400 | $75.16 | $30k | 735,686 | Jan 12, 2026 |
| Jan 8, 2026 | Neil Kumar Chief Executive Officer | SOpen-market sale Common Stockindirect: By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -11,565 | $73.65 | $852k | 4,546,882 | Jan 12, 2026 |
| Jan 8, 2026 | Neil Kumar Chief Executive Officer | SOpen-market sale Common Stockindirect: By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -8,135 | $74.38 | $605k | 4,538,747 | Jan 12, 2026 |
| Jan 8, 2026 | Neil Kumar Chief Executive Officer | SOpen-market sale Common Stockindirect: By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -300 | $75.20 | $23k | 4,538,447 | Jan 12, 2026 |
| Jan 9, 2026 | Neil Kumar Chief Executive Officer | SOpen-market sale Common Stockindirect: By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -2,151 | $75.75 | $163k | 733,535 | Jan 12, 2026 |
| Jan 9, 2026 | Neil Kumar Chief Executive Officer | SOpen-market sale Common Stockindirect: By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -6,955 | $76.72 | $534k | 726,580 | Jan 12, 2026 |
| Jan 9, 2026 | Neil Kumar Chief Executive Officer | SOpen-market sale Common Stockindirect: By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -10,519 | $77.61 | $816k | 716,061 | Jan 12, 2026 |
| Jan 9, 2026 | Neil Kumar Chief Executive Officer | SOpen-market sale Common Stockindirect: By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -375 | $78.19 | $29k | 715,686 | Jan 12, 2026 |
| Jan 9, 2026 | Neil Kumar Chief Executive Officer | SOpen-market sale Common Stockindirect: By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -1,401 | $75.61 | $106k | 4,537,046 | Jan 12, 2026 |
| Jan 9, 2026 | Neil Kumar Chief Executive Officer | SOpen-market sale Common Stockindirect: By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -6,067 | $76.53 | $464k | 4,530,979 | Jan 12, 2026 |
| Jan 9, 2026 | Neil Kumar Chief Executive Officer | SOpen-market sale Common Stockindirect: By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -10,677 | $77.46 | $827k | 4,520,302 | Jan 12, 2026 |
| Jan 9, 2026 | Neil Kumar Chief Executive Officer | SOpen-market sale Common Stockindirect: By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -1,855 | $78.10 | $145k | 4,518,447 | Jan 12, 2026 |
| Dec 12, 2025 | Maricel Apuli Chief Accounting Officer | FTax withholding Common Stock | -2,003 | $75.15 | $151k | 128,294 | Dec 16, 2025 |
| Dec 12, 2025 | Thomas Trimarchi President and CFO | FTax withholding Common Stock | -13,826 | $75.15 | $1.0M | 369,004 | Dec 16, 2025 |
| Dec 12, 2025 | Neil Kumar Chief Executive Officer | MOption exercise Common Stock10b5-1 | +60,975 | - | - | 289,751 | Dec 16, 2025 |
| Dec 12, 2025 | Neil Kumar Chief Executive Officer | FTax withholding Common Stock10b5-1 | -30,964 | $75.15 | $2.3M | 258,787 | Dec 16, 2025 |
| Dec 15, 2025 | Neil Kumar Chief Executive Officer | SOpen-market sale Common Stock10b5-1 | -28,311 | $74.60 | $2.1M | 230,476 | Dec 16, 2025 |
| Dec 15, 2025 | Neil Kumar Chief Executive Officer | SOpen-market sale Common Stock10b5-1 | -1,700 | $75.24 | $128k | 228,776 | Dec 16, 2025 |
| Dec 12, 2025 | Neil Kumar Chief Executive Officer | MOption exercise Restricted Stock Unitsderivative10b5-1 | -60,975 | $0.00 | $0 | 60,976 | Dec 16, 2025 |
| Dec 8, 2025 | Maricel Apuli Chief Accounting Officer | SOpen-market sale Common Stock10b5-1 | -2,000 | $74.26 | $149k | 130,297 | Dec 10, 2025 |
| Dec 4, 2025 | Neil Kumar Chief Executive Officer | SOpen-market sale Common Stockindirect: By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -2,100 | $73.16 | $154k | 793,586 | Dec 8, 2025 |
| Dec 4, 2025 | Neil Kumar Chief Executive Officer | SOpen-market sale Common Stockindirect: By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -12,192 | $74.42 | $907k | 781,394 | Dec 8, 2025 |
| Dec 4, 2025 | Neil Kumar Chief Executive Officer | SOpen-market sale Common Stockindirect: By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -5,708 | $74.80 | $427k | 775,686 | Dec 8, 2025 |
| Dec 5, 2025 | Neil Kumar Chief Executive Officer | SOpen-market sale Common Stockindirect: By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -12,517 | $73.05 | $914k | 763,169 | Dec 8, 2025 |
| Dec 5, 2025 | Neil Kumar Chief Executive Officer | SOpen-market sale Common Stockindirect: By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -7,483 | $73.76 | $552k | 755,686 | Dec 8, 2025 |
| Dec 4, 2025 | Neil Kumar Chief Executive Officer | SOpen-market sale Common Stockindirect: By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -2,100 | $73.16 | $154k | 4,596,347 | Dec 8, 2025 |
| Dec 4, 2025 | Neil Kumar Chief Executive Officer | SOpen-market sale Common Stockindirect: By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -12,200 | $74.42 | $908k | 4,584,147 | Dec 8, 2025 |
| Dec 4, 2025 | Neil Kumar Chief Executive Officer | SOpen-market sale Common Stockindirect: By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -5,700 | $74.80 | $426k | 4,578,447 | Dec 8, 2025 |
| Dec 5, 2025 | Neil Kumar Chief Executive Officer | SOpen-market sale Common Stockindirect: By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -12,288 | $73.04 | $898k | 4,566,159 | Dec 8, 2025 |
| Dec 5, 2025 | Neil Kumar Chief Executive Officer | SOpen-market sale Common Stockindirect: By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -7,712 | $73.75 | $569k | 4,558,447 | Dec 8, 2025 |
| Nov 20, 2025 | Neil Kumar Chief Executive Officer | SOpen-market sale Common Stock10b5-1 | -6,401 | $64.97 | $416k | 248,531 | Nov 24, 2025 |
| Nov 20, 2025 | Neil Kumar Chief Executive Officer | SOpen-market sale Common Stock10b5-1 | -14,299 | $65.90 | $942k | 234,232 | Nov 24, 2025 |
| Nov 20, 2025 | Neil Kumar Chief Executive Officer | SOpen-market sale Common Stock10b5-1 | -5,456 | $66.71 | $364k | 228,776 | Nov 24, 2025 |
| Nov 17, 2025 | Andrew Lo director | SOpen-market sale Common Stock | -36,801 | $66.63 | $2.5M | 17,887 | Nov 19, 2025 |
| Nov 17, 2025 | Randal W. Scott director | MOption exercise Common Stock10b5-1 | +10,000 | $16.75 | $168k | 21,589 | Nov 19, 2025 |
| Nov 17, 2025 | Andrew Lo director | SOpen-market sale Common Stock | -3,798 | $67.06 | $255k | 14,089 | Nov 19, 2025 |
| Nov 17, 2025 | Randal W. Scott director | SOpen-market sale Common Stock10b5-1 | -3,801 | $66.25 | $252k | 17,788 | Nov 19, 2025 |
| Nov 18, 2025 | Andrew Lo director | SOpen-market sale Common Stockindirect: By Andrew W. Lo and Nancy N. Lo JTWROS | -24,007 | $65.23 | $1.6M | 81,576 | Nov 19, 2025 |
| Nov 17, 2025 | Randal W. Scott director | SOpen-market sale Common Stock10b5-1 | -6,199 | $66.89 | $415k | 11,589 | Nov 19, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Maricel ApuliChief Accounting Officer
- Ronald J Danielsdirector
- Andrea Ellisdirector
- Charles J Homcydirector
- KKR Genetic Disorder L.P.owner
- Neil KumarChief Executive Officer
- Andrew Lodirector
- Frank McCormickdirector
- Brian C StephensonCFO and Treasurer
- Randal W. Scottdirector
- Thomas TrimarchiPresident and CFO
- Viking Global Investors LPowner
- Hannah Valantinedirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.